chrM-8393-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4BP6_ModerateBS1BS2
The ENST00000361851.1(MT-ATP8):c.28C>T(p.Pro10Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P10L) has been classified as Uncertain significance.
Frequency
Mitomap GenBank:
𝑓 0.0051 ( AC: 311 )
Consequence
MT-ATP8
ENST00000361851.1 missense
ENST00000361851.1 missense
Scores
Apogee2
Benign
Clinical Significance
Reversible-brain-pseudoatrophy
Conservation
PhyloP100: -0.220
Genes affected
MT-ATP8 (HGNC:7415): (mitochondrially encoded ATP synthase 8) Contributes to proton-transporting ATP synthase activity, rotational mechanism. Involved in mitochondrial ATP synthesis coupled proton transport. Part of mitochondrial proton-transporting ATP synthase complex. Implicated in multiple sclerosis and urinary bladder cancer. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Apogee2 supports a benign effect, 0.04838793 < 0.5 .
BP6
Variant M-8393-C-T is Benign according to our data. Variant chrM-8393-C-T is described in ClinVar as [Benign]. Clinvar id is 9638.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
High frequency in mitomap database: 0.0050999997
BS2
High AC in GnomadMitoHomoplasmic at 274
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP8 | ATP8.1 use as main transcript | c.28C>T | p.Pro10Ser | missense_variant | 1/1 | YP_003024030.1 | ||
TRNK | TRNK.1 use as main transcript | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MT-ATP8 | ENST00000361851.1 | c.28C>T | p.Pro10Ser | missense_variant | 1/1 | ENSP00000355265 | P1 | |||
MT-TK | ENST00000387421.1 | downstream_gene_variant |
Frequencies
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
Mitomap GenBank
AF:
AC:
311
Gnomad homoplasmic
AF:
AC:
274
AN:
56434
Gnomad heteroplasmic
AF:
AC:
2
AN:
56434
Alfa
AF:
Hom.:
Mitomap
Reversible-brain-pseudoatrophy
ClinVar
Significance: Benign
Submissions summary: Benign:1Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Leigh syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine | Oct 17, 2019 | The NC_012920.1:m.8393C>T (YP_003024030.1:p.Pro10Ser) variant in MTATP8 gene is interpretated to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes: BS1, BS2 - |
Brain pseudoatrophy, reversible, valproate-induced, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Nov 14, 2006 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Apogee2
Benign
Hmtvar
Pathogenic
AlphaMissense
Benign
BayesDel_addAF
Benign
T
DEOGEN2
Benign
T
LIST_S2
Benign
T
MutationTaster
Benign
N
PROVEAN
Benign
N
Sift
Benign
T
Sift4G
Benign
T
GERP RS
Varity_R
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at